The company reported sales of $702.47 million, up 13% year-over-year, beating the consensus of $696.80 million. Generic net ...

National settlements with two generic drug companies over allegedly massive price-fixing conspiracies could be the first of ...

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...

Attorney General Keith Ellison celebrates settlements with two drug companies he accused of “scheming” to raise prices on ...

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

The lawsuit, which was filed in 2017, alleged that Walgreens required insured customers to pay more than members of its ...

Walgreen Co. will pay $100 million and terminate its generic drug discount program to resolve a seven-year-old class action ...

Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.